Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100148682 | 10014868 | 2 | F | 20160824 | 20140317 | 20160829 | EXP | US-PFIZER INC-2014069525 | PFIZER | 0.00 | Y | 0.00000 | 20160829 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100148682 | 10014868 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | UNK AS DIRECTED | U | 20702 | FILM-COATED TABLET | ||||||||
| 100148682 | 10014868 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 20702 | FILM-COATED TABLET | ||||||||||
| 100148682 | 10014868 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 20702 | FILM-COATED TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100148682 | 10014868 | 1 | Low density lipoprotein increased |
| 100148682 | 10014868 | 2 | Cardiovascular event prophylaxis |
| 100148682 | 10014868 | 3 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100148682 | 10014868 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100148682 | 10014868 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |